Overview

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

Status:
Completed
Trial end date:
2014-10-31
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The intention of this health service research study is to obtain data from daily routine to evaluate the quality of life and the costs of the disease for patients with type 2 diabetes mellitus.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc
Liraglutide